Skip to main content

Day: July 27, 2020

EDENRED : First-half 2020 results – Edenred shows good resilience in the first half and a strong capacity to rebound thanks to its technological leadership 

Press releaseJuly 27, 2020First-half 2020 resultsEdenred shows good resilience in the first half and a strong capacity to rebound thanks to its technological leadership FIRST-HALF 2020 RESULTSDue to the current situation in Venezuela, the like-for-like performance and the currency effect are temporarily calculated excluding the country. Changes are calculated based on 2019 pro forma figures, which reflect the change in the breakdown between operating revenue and other revenue within total revenue in Brazil, effective since fourth‑quarter 2019 and with no impact on full-year 2019 total revenue. See the appendices, page 17.At its meeting on July 24, 2020, the Board of Directors reviewed the Group’s consolidated financial statements for the six months ended June 30, 2020.First-half 2020 key financial metrics:·Total revenue: €696 millionTotal...

Continue reading

EDENRED : Résultats du premier semestre 2020 – Bonne résistance au premier semestre et forte capacité de rebond d’Edenred grâce à son leadership technologique

Communiqué de presse27 juillet 2020Résultats du premier semestre 2020Bonne résistance au premier semestre et forte capacité de rebond d’Edenred grâce à son leadership technologiqueRÉSULTATS DU PREMIER SEMESTRE 2020Compte tenu de la situation actuelle au Venezuela, les croissances en données comparables et les effets de change excluent temporairement ce pays. Les variations sont calculées sur la base des chiffres proforma 2019, tenant compte du changement de classification au Brésil depuis le quatrième trimestre 2019, au sein du revenu total, entre chiffre d’affaires opérationnel et autres revenus, sans effet sur le revenu total 2019. Voir annexes, page 18.Lors de sa séance du 24 juillet 2020, le Conseil d’administration a examiné les comptes consolidés semestriels du Groupe au 30 juin 2020.Principaux agrégats financiers du premier semestre...

Continue reading

Atos to acquire EcoAct, leader in decarbonization strategy consulting

Paris, July 27, 2020 – Atos, a global leader in digital transformation, today announces an agreement to acquire EcoAct, an internationally recognized carbon reduction strategy consulting firm. This acquisition will support Atos’ decarbonization ambition by enriching its portfolio of carbon reduction digital solutions, services and strategies to further support its clients at every stage of their journeys towards carbon neutrality.EcoAct is a global market leader in developing innovative carbon reduction strategies, delivering to 400+ clients through four international offices. Its comprehensive “A to Zero” offer based on the five-module approach supports organizations at every stage of their journeys towards low-carbon operations and long-term commercial resilience. Its unique portfolio, combined with Atos’ digital offerings, will give...

Continue reading

Atos annonce le projet d’acquisition d’EcoAct, leader du conseil en stratégie de décarbonation

Paris, le 27 juillet 2020 – Atos, leader international de la transformation digitale, annonce avoir signé un accord en vue d’acquérir EcoAct, une société de conseil en stratégie de réduction des émissions de carbone, reconnue au niveau international. Cette acquisition soutiendra l’ambition d’Atos en matière de décarbonation et enrichira son portefeuille de solutions, services et stratégies numériques de réduction des émissions carbone afin d’accompagner ses clients à chaque étape de leur cheminement vers la neutralité carbone.EcoAct est un leader mondial dans l’élaboration de stratégies innovantes de réduction carbone, qui fournit des services à plus de 400 clients par l’intermédiaire de quatre bureaux internationaux. Son offre complète “A to Zero”, basée sur une approche en cinq modules, soutient...

Continue reading

WISeKey Appoints Ben Stump as Chief Revenue Officer to Drive the Next Phase of its Global Growth

WISeKey Appoints Ben Stump as Chief Revenue Officer to Drive the Next Phase of its Global GrowthGeneva, Switzerland – July 27, 2020: WISeKey International Holding Ltd. (“WISeKey”) (SIX: WIHN, NASDAQ: WKEY), a leading global cybersecurity and IoT company, announced today that it has appointed Ben Stump as its Chief Revenue Officer with global responsibility for sales and marketing.  Mr. Stump brings nearly 25 years of experience and proven success in sales, marketing, innovation and technology.“Ben is an accomplished leader with deep industry expertise who is a welcomed addition to our executive leadership team,” said Carlos Moreira, WISeKey’s Founder and CEO.  “His leadership experience in Digital Transformation, IoT ecosystems and Brand Protection, coupled with his strategic sales approach will deliver market leading solutions that provide...

Continue reading

MDxHealth (R):

Press Release   27 July 2020, 7:00 CETMDxHealth Announces Inclusion of SelectMDx in2020 NCCN Guidelines for Prostate Cancer Early DetectionIRVINE, CA – June 27, 2020 – MDxHealth, a commercial-stage innovative molecular diagnostics company, today announced that its SelectMDx for Prostate Cancer test has been included in the 2020 National Comprehensive Cancer Network (NCCN) Guidelines for Prostate Cancer Early Detection.“We are pleased that SelectMDx has joined ConfirmMDx in the NCCN guidelines and believe this is an important milestone and serves as additional validation for the clinical utility and importance of using biomarker tools in the detection of prostate cancer,” said Michael McGarrity, CEO of MDxHealth. “Our prostate cancer menu of tests can and will help improve patient outcomes.”The NCCN Guidelines are updated regularly to...

Continue reading

First half 2020 results

Strong commercial dynamicOrder entry up +9.4% year-on-year, Book to bill ratio at 112% (Q2 at 121%)Revenue at € 5,627 million, -2.8% organically (Q2 at -4.8%)Cost actions leading to an Operating margin at € 450 million, 8.0% of revenueWorking capital timing effects leading to a Free cash flow at € -172 millionNormalized diluted EPS at € 2.93Cybersecurity and Decarbonization acquisitions announced todayAll 2020 objectives confirmedParis, July 27, 2020 – Atos, a global leader in digital transformation, today announced its financial results for the first half of 2020.Elie Girard, CEO, said: “During the first half of 2020, in the very specific context of the pandemic, we prioritized the health and safety of our people, while ensuring business continuity to our customers by delivering critical services supported by our resilient business...

Continue reading

Résultats du premier semestre 2020

 Une forte dynamique commercialeDes prises de commandes en hausse de +9.4%, un ratio prise de commandes sur chiffre d’affaires de 112% (121% au deuxième trimestre)Un chiffre d’affaires à 5 627 millions d’euros, -2,8% à périmètre et taux de change constants (-4,8% au deuxième trimestre)Des actions fortes sur les coûts conduisant à une marge opérationnelle de 450 millions d’euros, soit 8,0% du chiffre d’affairesDes décalages temporaires sur le besoin en fonds de roulement portant le flux de trésorerie disponible à -172 millions d’eurosUn Bénéfice Normalisé par Action Dilué à 2,93 €Acquisitions en Cybersécurité et en Décarbonation annoncées aujourd’huiTous les objectifs 2020 sont confirmésParis, le 27 juillet 2020 Atos, leader international de la transformation digitale, annonce aujourd’hui ses résultats financiers pour le premier semestre...

Continue reading

Acacia Pharma Advances Preparations for US Launch of BARHEMSYS®

Acacia Pharma Advances Preparations for US Launch of BARHEMSYS®Second API Supplier for BARHEMSYS® Receives FDA ApprovalThis announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.Cambridge, UK and Indianapolis, US – 27 July 2020: Acacia Pharma Group plc (“Acacia Pharma” or the “Company”) (EURONEXT: ACPH), announces that the US Food and Drug Administration (FDA) has approved of a second supplier for the active pharmaceutical ingredient (API) for BARHEMSYS® (amisulpride injection). BARHEMSYS was approved for the treatment and prevention of PONV in the US in February 2020.The approval significantly increases the Company’s commercial product stock levels ahead of the US launch of BARHEMSYS. The Company anticipates the approval of a second supplier will support its ability to...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.